Evicenter
Leqvio (inclisiran) in Hypercholesterolemia
Manufacturer
Novartis Pharmaceuticals Corporation
Prescribing information
Leqvio (opens in a new tab)
Questions
17
Last updated

All questions

Indication: Leqvio (inclisiran) in hypercholesterolemia

1 question · 1 source

Indication

What is Leqvio approved for?

Note: The Prescribing Information (revised 08/2026) also lists indications in adults and pediatric patients 12 years and older with heterozygous familial hypercholesterolemia and in pediatric patients 12 years and older with homozygous familial hypercholesterolemia; this page covers the adult hypercholesterolemia indication. The Leqvio HCP site's indication statement, as captured on November 14, 2026, reads "adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH)".